Mats Nordin, Verbatim Ltd, Summer 2015 Ownership Structure

Total Page:16

File Type:pdf, Size:1020Kb

Mats Nordin, Verbatim Ltd, Summer 2015 Ownership Structure Mats Nordin, Verbatim Ltd, Summer 2015 Ownership Structure MCHC Group consists of four core business companies: Mitsubishi Chemical Corporation, Mitsubishi Tanabe Pharma Corporation, Mitsubishi Plastics, Inc., and Mitsubishi Rayon, Co., Ltd., and their 429 Subsidiaries & Affiliates. Net sales: US$ 32.9 Bn. (March 31, 2013).* Eemployees: 55,131 100% subsidiary company of Mitsubishi Chemical Corporation. 100% subsidiary of Mitsubishi Kagaku Media Co., Ltd *US Dollar amounts are converted from Yen at the rate of Y94 = US$1.00 Mitsubishi Chemical Holdings Group 2 Mitsubishi Chemical Holdings Main Business Sectors Electronics related products Recording media Information materials Food ingredients Pharmaceuticals Battery materials Diagnostic reagents and instruments Fine chemicals Performance Products Health Care Polymer processing Electronics Applications Segment Health Care Segment materials Designed Materials Segment Clinical testing Composite materials Inorganic chemicals Chemical Fibers Water Treatment Industrial Materials Basic petrochemicals Chemicals Segment Neat resins and composites Polymers Segment Chemical derivatives Carbon products Synthetic fiber materials Mitsubishi Chemical Holdings Group 3 Mitsubishi Chemical’s Focus Growth business: White LED Lighting & Materials Lithium-ion Battery Materials Solar Panels Water Treatment Systems & Services Flat panel display components Performance composite materials High-performance molding products Solar panels Batteries Water Cleaning Mitsubishi Chemical Holdings Group MCC Performance Products A market leader in Gallium Nitride Mitsubishi Chemical Corporation plans to Substrates, Phosphors & Encapsulants incorporate Europe’s only Flexible Solar This became a growth business under Cells in their construction materials. This APTSIS 15. We are reinforcing our market move comes as Japanese energy legislation leadership in gallium nitride (GaN) tightens and companies look for more energy substrates, phosphors, and encapsulants efficient solutions. VHF-Technologies’ and packaging materials. Another focus is to innovative solar cells, manufactured in globally cultivate our Verbatim brand to Switzerland, are a mere 50 microns thick and market KAITEKI lighting by capitalizing on potentially cheaper than their silicon our strength in materials. We are boosting crystalline counterparts. Their selling point: production capacity for vapor-phase growth the weight of the solar panels can be spread substrates and will begin mass across a building’s exterior, a major plus for production of liquid-phase substrates, structures with weak roof materials increasing capacity 200-fold by FY2015. Mitsubishi Chemical Holdings Group MCC Performance Products Aiming to provide total solutions in The only manufacturer providing all Water Treatment Systems around the four core components world We seek global leadership in lithium-ion We are expanding our industrial water battery (LiB) materials for electric and hybrid reclamation business using membrane electric vehicles. The MCHC Group is the bioreactors, centered on polyvinylidene world’s sole supplier of all four core LiB fluoride membranes, in the PRC and materials, namely electrolytes, anodes, Southeast Asia. We will improve our cost- cathodes, and separators. We are developing competitiveness and further deploy our a global supply structure by boosting capacity industry-leading microporous hollow-fiber in Japan, while building plants in the membrane technology. We will expand United States, Europe, and the PRC. global sales of CLEANSUI in the PRC and Asia. Mitsubishi Chemical Holdings Group Mitsubishi Chemical’s Focus “...The Mitsubishi Chemical Holding Group will respond to changes in the global environment with our integrated chemical strength to contribute to reduce dependence on fossil fuels...” Mitsubishi Chemical Holdings Group Our partners include... Mitsubishi Chemical Holdings Group Verbatim LED HOME Range Mats Nordin, Summer 2015 HOME Range A range of attractive LED lamps for the home, designed to be sold through retail outlets PACKAGING FEATURES - Integrated RF chip to protect against theft - Clear blister design makes whole product visible - Hangs on Euro Hook or stands free on the shelf - Compact design with easy to understand messaging for end users - Non Dimmable products - Lifetime of >20.000h - 2700K Warm White Mitsubishi Chemical Holdings Group HOME Range Blister Pack 2700K Warm White HOME Range Mitsubishi Chemical Holdings Group 12 HOME Range (Non Dimmable) PN Equivalent Product description 52600 40W Classic A E27 - 6.0W 2700K 480LM >220˚ Frosted 52619 40W Classic A B22 - 6.0W 2700K 480LM >220˚ Frosted 52601 60W Classic A E27 - 9.0W 2700K 810LM >220˚ Frosted 52612 60W Classic A B22 - 9.0W 2700K 810LM >220˚ Frosted 52602 31W Candle E14 - 4.5W 2700K 350LM Frosted 52603 25W Candle E14 - 4.5W 2700K 250LM Clear 52604 31W Candle E14 - 5.0W 2700K 350LM Clear 52623 25W Candle B22 -4.5W 2700K 250LM Clear 52605 31W Mini Globe E14 - 5.0W 2700K 350LM Clear 52606 31W Mini Globe E27 - 5.0W 2700K 350LM Clear 52614 25W Mini Globe E27 - 3.5W 2700K 250LM Frost 52615 25W Mini Globe E14 - 3.5W 2700K 250LM Frost 52616 25W Mini Globe E27 - 4.5W 2700K 250LM Clear 52617 25W Mini Globe E14 - 4.5W 2700K 250LM Clear 52607 38W PAR16 GU10 - 4.0W 2700K 250LM 35˚ 52608 51W PAR16 GU10 - 5.0W 2700K 350LM 35˚ 52609 35W MR16 GU5.3 - 5.5W 2700K 350LM 35˚ 52618 20W MR16 GU5.3 - 4.5W 2700K 210LM 35˚ Mitsubishi Chemical Holdings Group 13 HOME Range (Dimmable) PN Equivalent Product description 52143 10W BI Pin G4 Capsule 1.0W 12V AC/DC 2700K 80LM DIM 52145 10W BI Pin G4 Round 1.5W 12V AC/DC 2700K 85LM DIM 52144 15W MR11 GU4 2.0W 2700K - 90LM 35˚DIM 52147 25W Classic A E27 4.0W 2700K WW 250LM 130˚ DIM 52149 43W Classic A B22 8.0W 2700K WW 530LM 130˚ DIM 52150 55W Classic A E27 10.0W 2700K WW 730LM 130˚ DIM 52151 55W Classic A B22 10.0W 2700K WW 730LM 130˚ DIM Mitsubishi Chemical Holdings Group 14 HOME Range (Special Lamps) PN Equivalent Product description 52610 40W E27/G95 Globe 7W 2700K WW 470LM 220˚DIM 52611 60W E27/G95 Globe 10W 2700K WW 810LM 220˚DIM 52620 17W BI PIN G4 Capsule 2.3W 12V AC/ADC 2700K 160LM 52622 17W BI PIN G9 2W-17W ND 2700K 160LM 52621 R7s 8.5W 3000K 650LM 52624 85W PAR30 E27 12W - 2700K 35˚ 720LM 52625 116W PAR38 E27 15W - 2700K 35˚ 1000LM G95 Globe PAR30 PAR38 G4 G9 R7s Mitsubishi Chemical Holdings Group 15 HOME Range Top SKU (non Dimmable) PN Equivalent Product description 52600 40W Classic A E27 - 6.0W 2700K 480LM >220˚ Frosted 52601 60W Classic A E27 - 9.0W 2700K 810LM >220˚ Frosted 52602 31W Candle E14 - 4.5W 2700K 350LM Frosted 52603 25W Candle E14 - 4.5W 2700K 250LM Clear 52604 31W Candle E14 - 5.0W 2700K 350LM Clear 52605 31W Mini Globe E14 - 5.0W 2700K 350LM Clear 52606 31W Mini Globe E27 - 5.0W 2700K 350LM Clear 52607 38W PAR16 GU10 - 4.0W 2700K 250LM 35˚ 52608 51W PAR16 GU10 - 5.0W 2700K 350LM 35˚ 52609 35W MR16 GU5.3 - 5.5W 2700K 350LM 35˚ Mitsubishi Chemical Holdings Group 16 HOME Range USP Unique Selling Points: Very High Quality products with attractive price (just feel the weight of the product) LED lamps for most popular applications Wide beam angle for the classic models gives a very nice light distribution Switch Cycles >100.000 cycles (now tested and approved for >100.000 cycles) Long lasting at >20.000 lifetime hours (now tested and approved for >20.000h) Range with most used & appriciated beam angle (Classic >220˚ and Spot 35˚) Exclusive white sleek Aluminium heatsink design, Unique “airflow through“ Aluminium heatzink construction (for perfect Spot Thermal management) Available in a nice designed blister with RF tag, for shop security 3 year warranty Verbatim offer full End User Support via Verbatim web page 17 EUMEA SALES CONFERENCE 2013 | Company Confidential Mitsubishi Chemical Holdings Group Fact continue... Unique “Air through” flow cooling through Heatzink HOME Line Aluminium Heatzink Design Blister and Product Design HOME Line Aluminium Heatzink Design Mitsubishi Chemical Holdings Group 18 HOME Range E27/G95 NOW in Stock! Mitsubishi Chemical Holdings Group HOME Range PAR30/38 G4/G9/R7s G9 PN:52622 PAR30 PN:52624 PAR38 PN:52625 G4 R7s PN:52621 PN:52621 Mitsubishi Chemical Holdings Group 20 Verbatim LED Customer Support Go to: http://www.verbatim-europe.co.uk/en_1/support.html Verbatim Support Centre for LED Products: Go to: http://www.verbatim- europe.co.uk/en_1/support.html 1) Select Category 2) Select Sub Category 3) Select Product. Here will you find all useful info about the product. 4) If needed Use the Direct Phone or e- mail for additional support. Mitsubishi Chemical Holdings Group Verbatim LED Customer Support Go to: http://www.verbatim -europe.co.uk/en_1/support.html Verbatim Support Centre for LED Products: Any End User that have a problem or issue with a Verbatim LED product ,can go direct to the Verbatim Support Centre page and get Support Direct through Phone or e- mail. See Sample Next> Mitsubishi Chemical Holdings Group Verbatim LED Customer Support Go to: http://www.verbatim -europe.co.uk/en_1/support.html Verbatim Support Centre for LED Products: Any End User that have a problem or issue with a Verbatim LED product , can go direct to the Verbatim Support Centre page and get Support Direct through Phone or e- mail. Mitsubishi Chemical Holdings Group New Product Update Q2 2015 Home Range Mitsubishi Chemical Holdings Group New Products Arrived – April ‘15 In Stock! PN: 52624 PAR30 - E27 - 12W (85W eqv.) 720lm 2700K, BA 35° 85W Replacement PN: 52625 PAR38 - E27 - 15W - (116W eqv.) 1000lm
Recommended publications
  • Mitsubishi Chemical Holdings Corporation Condensed
    May 10, 2012 Mitsubishi Chemical Holdings Corporation Condensed Consolidated Financial Information for the Fiscal Year Ended March 31, 2012 1. Business Results for the Fiscal Year Ended March 31, 2012 (Business period: April 1, 2011 to March 31, 2012) Thousands of Millions of Yen U.S. Dollars FY2011 FY2010 FY2011 April 1, 2011 - April 1, 2010 - April 1, 2011 - March 31, 2012 March 31, 2011 March 31, 2012 (1) Results of Operations: Net sales 3,208,168 3,166,771 39,124,000 Operating income 130,579 226,493 1,592,427 Income before income taxes and minority interests 127,474 169,552 1,554,561 in consolidated subsidiaries Net income 35,486 83,581 432,756 Comprehensive income 64,199 86,742 782,915 (2) Financial Position: Total assets 3,173,970 3,294,014 38,706,951 Inventories 516,096 485,061 6,293,854 Property, plant and equipment 1,032,738 1,088,369 12,594,366 Short-term and long-term debts 1,164,128 1,304,589 14,196,683 Shareholders' equity* 770,729 758,247 9,399,134 Ratio of shareholders' equity to total assets (%) 24.2 23.0 * Net assets excluding share subscription rights and minority interests (3) Cash Flows: Net cash provided by operating activities 217,954 288,853 2,657,976 Net cash used in investing activities (63,404) (101,064) (773,220) Net cash provided by (used in) financing activities (164,146) (149,493) (2,001,780) Cash and cash equivalents at end of the year 133,055 143,747 1,622,622 (4) General: Capital expenditures 116,145 117,806 1,416,402 Depreciation and amortization 145,695 148,697 1,776,768 R&D expenditures 138,545 130,825 1,689,573 Employees (number) 53,979 53,882 (5) Per Share: (Yen) (U.S.
    [Show full text]
  • November 18, 2019 Announcement of Commencement of Tender Offer For
    November 18, 2019 Company name: Mitsubishi Chemical Holdings Corporation Representative: Hitoshi Ochi Representative Corporate Executive Officer, President & Chief Executive Officer TSE code no.:4188, 1st section Contact: Habuka Shigeki Corporate Executive Officer, General Manager, Public Relations and Investor Relations Office Tel: +81 (0)3-6748-7120 Announcement of Commencement of Tender Offer for Shares of Mitsubishi Tanabe Pharma Corporation (Securities Code: 4508) Mitsubishi Chemical Holdings Corporation (the “Company” or the “Tender Offeror”) announces that it has decided to acquire common stock (the “Target Company Common Stock”) of Mitsubishi Tanabe Pharma Corporation (Tokyo Stock Exchange, Inc. (“TSE”) code no.: 4508; the “Target Company”) through a tender offer (the “Tender Offer”) pursuant to the Financial Instruments and Exchange Act (Act No. 25 of 1948, as amended; “Act”). 1. Purpose of Tender Offer (1) Overview of the Tender Offer As of today, the Tender Offeror holds 316,320,069 shares (Share Holding Ratio (Note 1): 56.39%) of the Target Company common stock that are listed on the First Section of the TSE, and the Target Company is a consolidated subsidiary of the Tender Offeror. (Note 1) “Share Holding Ratio” means any shareholding ratio relative to the total number of issued shares of the Target Company as of September 30, 2019 (i.e., 561,417,916 shares), as set forth in the Second Quarterly Earnings Release for FY 2019 (IFRS) (Consolidated) disclosed by the Target Company on October 30, 2019 (referred to as the “Target Company’s FY 2019 Second Quarterly Earnings Release”), less the number of treasury shares (excluding the 200,279 shares that are held by the Officer Remuneration BIP (Board Inventive Plan) Trust (the “BIP Trust”) as of September 30, 2019) held by the Target Company as set forth in the Target Company’s FY 2019 Second Quarterly Earnings Release (i.e., 431,636 1 shares) (equating to 560,986,280 shares) (shareholding ratios are rounded up or down to three decimal places), and hereinafter the same shall apply.
    [Show full text]
  • KAITEKI Report
    INDEX R e p or t 2 0 11 Message from the President 3 Corporate Social Responsibility Response to the Great East Japan Earthquake 6 Editor’s Comments Mitsubishi Chemical Holdings' 11 To assist as many stakeholders as possible in understanding the Mitsubishi Social Responsibilities Chemical Holdings Group’s approach to CSR and the CSR activities pursued by the four operational companies (Mitsubishi Chemical Corporation, Mitsubishi Tanabe Pharma Corporation, Mitsubishi Plastics, Inc. and Mitsubishi Rayon Co., Ltd.), the 【Special Feature】 Initiatives toward KAITEKI 15 Group posts this information on its website and updates it annually. From fiscal 2011, our company is combining information about its conventional CSR Part 1 KAITEKI Management Initiatives 17 activities with that about its initiatives focusing on KAITEKI, the Group’s unique ■ The Three Axes of KAITEKI Management CSR concept, and disclosing the information in the form of the KAITEKI Report. ■ MOS Indexes that Visualize Our Contribution By communicating with a wide range of stakeholders via its website, Mitsubishi to SUSTAINABILITY Chemical Holdings Corporation will continue its initiatives toward KAITEKI. ■KAITEKI Project Organization About this Report Part 2 The Process of Creating MOS Indexes 25 In fiscal 2010, to disclose information to a greater number of stakeholders, while Part 3 KAITEKI Products and Technologies 36 being kind to the global environment, Mitsubishi Chemical Holdings Corporation abandoned this report’s paper version and began website-based publication. We will ■ White LED and OLED strive to capitalize on the advantages of the electronic medium to make the report Mitsubishi Chemical Corporation as clear as possible. A PDF version is also available so users can download the full report at one time.
    [Show full text]
  • KAITEKI REPORT 2020 N Introduction
    K Main Businesses A ITEKI R Mitsubishi Chemical Group Mitsubishi Tanabe Pharma Group E P Life Science Institute Group Nippon Sanso Holdings Group O RT 2020 Main businesses, products and services Main uses Optical films Information, Electronics and Electronics Display- and semiconductor-related Displays Optical clear adhesive Optical PVOH*1 film, Color resist sheet, CLEARFIT OPL film products Food packaging materials Foods and household goods High Performance Industrial-use films Industrial materials Films Food packaging film, Acrylic film, ACRYPLEN Moisture-proof PVC sheet DIAMIRON for tablet and capsule Medical and sanitary films packaging, VINYFOIL Medical care Aqua solutions Environment, infrastructure, household goods, medical care, foods Environment, energy, industrial-use chemicals, Ion-exchange resins electronics, medical care, foods Environment and Living Solutions Water treatment Hydroponic system FRP*2 panel water tank, Separator and aqua chemicals Environment, electronics, medical care, foods components, for leafy vegetables, HISHITANK equipment and Napperland Agricultural solutions Agriculture facilities Infrastructure solutions Environment, infrastructure, industrial materials High-performance engineering plastics Automobiles, electronics, industrial materials, medical care Advanced Carbon fiber and composite materials Automobiles, aircraft, industrial materials, sporting goods Moldings Alumina fibers Automobiles, industrial materials and Composites Engineering plastics Carbon fiber and Alumina fibers Functional moldings and
    [Show full text]
  • February 16, 2010 Mitsubishi Rayon Co., Ltd
    February 16, 2010 Mitsubishi Rayon Co., Ltd. Announcement of Opinion with Respect to Tender Offer conducted by Mitsubishi Chemical Holdings Corporation for Shares of Mitsubishi Rayon Co., Ltd. The Board of Directors of Mitsubishi Rayon Co., Ltd. (the “Company”) resolved, at a meeting held on February 16, 2010, to announce its opinion with respect to the tender offer conducted by Mitsubishi Chemical Holdings Corporation (the “Tender Offeror”) for the common stock of the Company (the “Tender Offer”). In connection with such resolution, we would like to provide notice of the following. The resolution at the meeting of the Company’s Board of Directors was based on the assumption that, if the Tender Offer is successful, the Tender Offeror will make the Company its wholly-owned subsidiary and that the shares of the Company may be delisted. 1. Description of the Tender Offeror (1) Trade Name Mitsubishi Chemical Holdings Corporation (2) Address of Head Office 14-1, Shiba 4-chome, Minato-ku, Tokyo Name and Title of (3) Yoshimitsu Kobayashi, President and CEO Representative (4) Business Description Management of the business activities of its group companies (including establishment of strategy for the whole group and distribution of resources) (5) Amount of Share Capital ¥50,000 million (as of February 16, 2010) (6) Date of Incorporation October 3, 2005 The Master Trust Bank of Japan Ltd. (Trust (7) Major Shareholders and 4.7% Shareholding Ratio Account) (as of September 30, 2009) Meiji Yasuda Life Insurance Company (Standing 4.0% proxy) Trust & Custody Services Bank, Ltd. Takeda Pharmaceutical Company Limited 3.4% The Bank of Tokyo-Mitsubishi UFJ, Ltd.
    [Show full text]
  • Mitsubishi Chemical Holdings Corporation Condensed Consolidated Financial Information for the Fist Nine Months of the Fiscal Year Ending March 31, 2010
    February 4, 2010 Mitsubishi Chemical Holdings Corporation Condensed Consolidated Financial Information For the Fist Nine Months of the Fiscal Year Ending March 31, 2010 1. Business Results for the First Nine Months of the Fiscal Year Ending March 31, 2010 (Business period: April 1, 2009 to December 31, 2009) Thousands of Millions of Yen U.S. Dollars April 1, 2009 - April 1, 2008 - April 1, 2009 - December 31, 2009 December 31, 2008 December 31, 2009 (1) Results of Operations: Net sales 1,792,384 2,331,163 19,482,435 Operating income 47,123 50,270 512,207 Income before income taxes and minority interests 36,957 33,129 401,707 in consolidated subsidiaries Net income 10,168 (11,401) 110,522 (Yen) (U.S. Dollars) Net income per share 7.38 (8.28) 0.08 Net income per share (diluted) 6.77 - 0.07 (2) Segment Information: [Net Sales by Segments] Electronics Applications 216,852 262,832 2,357,087 Designed Materials 204,834 220,012 2,226,457 Health Care 396,315 386,494 4,307,772 Chemicals 571,610 890,756 6,213,152 Polymers 297,801 456,997 3,236,967 Others 104,972 114,072 1,141,000 Total 1,792,384 2,331,163 19,482,435 [Operating Income (loss) by Segments] Electronics Applications 3,095 11,474 33,641 Designed Materials 6,352 2,524 69,043 Health Care 67,888 70,057 737,913 Chemicals 1,306 (22,870) 14,196 Polymers (26,156) (8,772) (284,304) Others 3,918 8,482 42,587 Elimination & corporate costs (9,280) (10,625) (100,870) Total 47,123 50,270 512,207 Thousands of Millions of Yen U.S.
    [Show full text]
  • Mitsubishi Tanabe Pharma Corporation Representative
    November 18, 2019 Name of company: Mitsubishi Tanabe Pharma Corporation Representative: Masayuki Mitsuka President & Representative Director (Code No.: 4508, TSE 1st Sec.) Contact: Yoshiaki Takai, Head of Corporate Communications Department (Tel: 06-6205-5211) Announcement of Mitsubishi Tanabe Pharma Corporation’s Opinion Regarding Tender Offer for Shares in Mitsubishi Tanabe Pharma Corporation by the Controlling Shareholder Mitsubishi Chemical Holdings Corporation, and Recommendation to Tender Shares Mitsubishi Tanabe Pharma Corporation (“MTPC”) hereby announces that it has resolved as stated below at its board of directors meeting held today to express its opinion in support of the tender offer for MTPC’s common shares (“MTPC Common Shares”) to be conducted by Mitsubishi Chemical Holdings Corporation (the “Tender Offeror”), the controlling shareholder (parent company) of MTPC (the “Tender Offer”), and to recommend that the shareholders of MTPC tender MTPC Common Shares in the Tender Offer. The resolution of the board of directors stated above was made on the assumption that the Tender Offeror intends to make MTPC its wholly-owned subsidiary by way of the Tender Offer and through a series of subsequent procedures and that MTPC Common Shares will be delisted. 1. Outline of Tender Offeror (1) Name Mitsubishi Chemical Holdings Corporation (2) Location 1-1 Marunouchi 1-chome, Chiyoda-ku, Tokyo (3) Name and title of Hitoshi Ochi, Representative Corporate Executive representative Officer, President & Chief Executive Officer (4) Description of business Management of group companies (Development of the group strategies and allocation of financial resource) (5) Capital 50,000 million yen (as of June 25, 2019) (6) Date of incorporation October 3, 2005 (7) Major shareholders and The Master Trust Bank of Japan, Ltd.
    [Show full text]
  • Briefing Regarding Acquisition of Mitsubishi Tanabe Pharma Corporation
    Briefing regarding Acquisition of Mitsubishi Tanabe Pharma Corporation November 18, 2019 Agenda 1. Overview of Transaction 2. Transaction Purpose and Rationale 3. Overview of MTPC 4. Financial Impact 1 Overview of Transaction Mitsubishi Chemical Holdings Corporation (“MCHC”) to make Mitsubishi Tanabe Pharma Corporation (“MTPC”) its wholly owned subsidiary through tender offer, commencing November 19, 2019 ◼ Target Company:MTPC ⚫ Number of shares held by MCHC before the transaction 316,320,069 shares; shareholding ratio of 56.39% ◼ Transaction Scheme:Tender Offer ⚫ Tender offer price:¥2,010 per share of common stock (Premium of 53.08% on 1,313, the closing price as of November 15, 2019) ◼ Number of Shares to be Purchased:244,666,211 Shares ⚫ All except for shares held by MCHC and treasury shares held by MTPC ⚫ Minimum number of shares to be purchased: 57,670,731 shares (two-thirds) (There is no maximum number of shares to be purchased) ◼ Transaction Value:c.¥ 491.8 billion (Assuming acquisition of all shares to be purchased) ◼ Schedule of Tender Offer ⚫ November 18, 2019: announcement of tender offer ⚫ November 19, 2019: commencement of tender offer period ⚫ January 7, 2020: end of tender offer period 2 Agenda 1. Overview of Transaction 2. Transaction Purpose and Rationale 3. Overview of MTPC 4. Financial Impact 3 MCHC Group's Transition of Portfolio Transformation Accelerating transformation to establish the resilient foundations and realize sustainable growth of the MCHC Group Acceleration of portfolio transformation: (Core) select and
    [Show full text]
  • Mitsubishi Chemical Holdings Corporation Condensed Consolidated Financial Information for the Fiscal Year Ended March 31, 2011 1
    May 11, 2011 Mitsubishi Chemical Holdings Corporation Condensed Consolidated Financial Information for the Fiscal Year Ended March 31, 2011 1. Business Results for the Fiscal Year Ended March 31, 2011 (Business period: April 1, 2010 to March 31, 2011) Thousands of Millions of Yen U.S. Dollars FY2010 FY2009 FY2010 April 1, 2010 - April 1, 2009 - April 1, 2010 - March 31, 2011 March 31, 2010 March 31, 2011 (1) Results of Operations: Net sales 3,166,771 2,515,079 38,153,867 Operating income 226,493 66,342 2,728,831 Income before income taxes and minority interests 223,899 58,990 2,697,578 in consolidated subsidiaries Net income 83,581 12,833 1,007,000 (2) Financial Position: Total assets 3,294,014 3,355,097 39,686,916 Inventories 485,061 474,732 5,844,108 Property, plant and equipment 1,088,369 1,167,073 13,112,880 Short-term and long-term debt 1,304,589 1,454,126 15,717,940 Shareholders' equity* 758,247 673,574 9,135,506 Ratio of shareholders' equity to total assets (%) 23.0 20.0 * Net assets excluding share subscription rights and minority interests (3) Cash Flows: Net cash provided by operating activities 288,853 116,073 3,480,157 Net cash used in investing activities (101,064) (327,006) (1,217,639) Net cash provided by (used in) financing activities (149,493) 94,437 (1,801,120) Cash and cash equivalents at end of the year 143,747 112,591 1,731,892 (4) General: Capital expenditures 117,806 119,025 1,419,349 Depreciation and amortization 148,697 129,574 1,791,530 R&D expenditures 130,825 136,863 1,576,205 Employees (number) 53,882 53,907 (5) Per Share: (Yen) (U.S.
    [Show full text]